Diaceutics PLC (LON:DXRX) Insider Graham Paterson Purchases 11,643 Shares

Diaceutics PLC (LON:DXRX) insider Graham Paterson bought 11,643 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were bought at an average cost of GBX 138 ($1.71) per share, for a total transaction of £16,067.34 ($19,922.31).

Diaceutics Stock Performance

Shares of DXRX stock opened at GBX 136.25 ($1.69) on Friday. The company has a quick ratio of 9.92, a current ratio of 4.85 and a debt-to-equity ratio of 2.93. Diaceutics PLC has a 52 week low of GBX 92.24 ($1.14) and a 52 week high of GBX 151 ($1.87). The firm has a market capitalization of £115.09 million, a PE ratio of -4,541.67 and a beta of 0.58. The company has a 50 day moving average price of GBX 130.24 and a 200-day moving average price of GBX 128.62.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on DXRX shares. Canaccord Genuity Group reaffirmed a “buy” rating and issued a GBX 160 ($1.98) price target on shares of Diaceutics in a research note on Tuesday, December 17th. Canaccord Genuity Group reissued a “buy” rating and set a GBX 160 ($1.98) price objective on shares of Diaceutics in a research report on Tuesday, December 17th.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.